Indeed, we did observe that RelB activity in prostate cancer tissues decreased the risk of recurrence associated with p65 nuclear localization, suggesting that RelB may interfere with the pro-tumoral function of the classical pathway. This evidence concerns the gene RELB and prostate carcinoma.